KIFFIK Biomedical Recognized as Top Biomarker Access Technology 2026 by Life Sciences Review
-
Bank of Korea Governor Shin Hyun-song Appointed First Asian Chair of BIS Payment Committee
-
Texas Car Buyers: Legal Remedies When a Defective Vehicle Isn't a 'Lemon'
-
Northern California Jewish Sports Hall of Fame Announces 2026 Inductees
-
Phil Spencer on Housing Market Fairness: How Buyers and Sellers Navigate Falling Prices
-
Readers Debate GTA 6 Spin-offs, Server Strain, and Warner Bros. Decline in Games Inbox
-
Moderna to Present at Upcoming Conference in November 2026
-
Apex Extends Trinity Zone in West Step-out Drilling With 2.52% REO Over 223.3 m and 2.49% REO Over 123.3 m at Rift
-
Electrovaya to Participate in Upcoming Investor Conferences
-
Aston Bay Announces Pre-Feasibility Study Results and Maiden Mineral Reserve for the Storm Copper Project, Nunavut
-
Zeb Nickel Commences Diamond Drilling at the Zeb Nickel Project
-
Silicon Publishing Launches Prism, Bringing AI-Assisted Automation to Database Publishing
-
Aztec Drills 70.1 Meters of 0.80 g/t AuEq (0.49 g/t Au and 16.85 g/t Ag) from Surface in TR26-54 at the Tombstone Project, Arizona
-
Critical Elements' 10,000-Meter Summer Drill Program at Rose West Continues to Deliver Positive Results
-
China Explores a New Pathway for Medical AI: Bridging R&D Innovation and Clinical Adoption
-
Gamma Resources Announces Planned Radon Flux Baseline Survey at Mesa Arc Uranium Project in New Mexico, Provides Update on Project Timelines
-
Geek+ Unveils 24/7 Warehouse Autonomy Plan to Advance Self-Optimizing, Around-the-Clock Operation
-
Precigen Posts Strong Q3: PAPZIMEOS Net Revenue Rose 37%; Positive Cash Flow Achieved Ahead of Schedule
-
Zomedica Announces "Third Friday at Four" Webinar on November 20, 2026: The People Behind Zomedica - Seven Guiding Principles in Action, and Q3 Financial Results
-
KIFFIK Biomedical Recognized as Top Biomarker Access Technology 2026 by Life Sciences Review
-
3D Induced Polarization Survey Identifies a Large Drill Target at East Goldfield
-
Spectrocell Strengthens Product Discovery and Customer Engagement with Bioz Badges
-
Fulcrum Metals PLC Announces Fulcrum to Increase Shareholding in Loyalist
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 10
-
New Gold IRA Investing Guide Explains How to Buy Gold in an IRA for American Consumers
-
ATWEC Technologies, Inc. (OTCID:ATWT) Reports Third Quarter 2026 Revenue of $12.46 Million, Up 37% Year-over-Year
-
INEO Invited to 15th Annual ROTH Technology Conference in New York
-
SMX Advances Development of its Scientific Intelligence, an AI-Powered Platform Intended to Create a Comprehensive Codex for Chemical Agents, Additives and Supplements
-
Jerash Holdings Reports Fiscal 2027 Second Quarter Financial Results
-
Four Nines Gold Intersects 67 Metres at 1.78 g/t Gold, Reinforing Emerging Gold Corridor at Hayden Hill
-
Peraso to Showcase DUNE 60 GHz Wireless Platform at Africa Tech Festival 2026
-
Your Patients Are Asking AI About You. AimwellBio Lets Every Physician See the Answer, Free.
-
ByNext Joins the Bilt Neighborhood: Reaching More Customers by Integrating Its Technology with Bilt Neighborhood OS
-
Cardiff Lexington To Report Third Quarter 2026 Financial Results and Host Conference Call on Monday, November 16, 2026
-
Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL
-
Adcore Reports Third Quarter 2026 Results: Gross Margin Rises to 64%, Operating Loss Halved, Cash Up to $4.3 Million as Restructuring Takes Hold
-
Odyssey Behavioral Healthcare Launches Virtual Intensive Outpatient Mental Health Treatment for Adults
-
Nextech3D.ai to Report Fiscal Second Quarter 2027 Financial Results and Host Investor Webinar on November 19, 2026 at 4:30 PM ET
-
Securitas Healthcare Introduces a New Era of RTLS Built for the Future of Healthcare Operations
-
Sterling Metals Announces Fully Allocated Private Placement of Units, Flow-Through Shares and Charity Flow-Through Units
-
Wash100 Award, GovCon Industry's Highest Honor, Opens Nominations for 2027 Season
-
Greene Concepts Highlights Groundwater Resources and Commercial Opportunities
-
SNZweig Forms AEC Industry Advisory Council
-
Allstar Health Brands Confirms MLS NEXT Expansion Bid to Anchor a Permanent Training Structure and a Professional Pathway
-
BioTech Breakthrough Acknowledges Champions Oncology Innovation with the "Contract Research and Development Innovation Award"
-
US Government Questions Effectiveness of Waymo’s School Bus Software Fix
-
Egypt to Launch 'Noor Saghir' Childhood Cancer Initiative in January 2027
-
Marie Schreiber Reflects on European Championships Demotion
-
First-time boat buyers advised to assess full ownership costs
-
Panthers expected to begin 2027 NRL season away from new stadium
-
Planning and preparation can reduce stress of interstate relocation
KIFFIK Biomedical Recognized as Top Biomarker Access Technology 2026 by Life Sciences Review
Publication Features KIFFIK Chief Scientific Officer Gino Martini, PhD
MIAMI, FL / ACCESS Newswire / November 10, 2026 / KIFFIK Biomedical Inc. ("KIFFIK"), a biotechnology company developing technology designed to provide non-invasive access to interstitial fluid (ISF), today announced that it has been recognized as Top Biomarker Access Technology 2026 by Life Sciences Review.
The recognition appears in the publication's October 2026 issue, featuring KIFFIK in an article titled "Expanding Practical, Non-Invasive Access to Interstitial Fluid." The article highlights insights from Luigi (Gino) Martini, PhD, KIFFIK's Chief Scientific Officer and CEO of PHTA Ltd, on the scientific opportunities enabled by practical access to ISF and the company's development of its proprietary K-EXP™ platform.
ISF is an information-rich biological fluid that surrounds nearly every cell in the body. Although ISF has been studied for decades, practical access has historically been challenging. KIFFIK's technology is designed to provide non-invasive access to ISF, supporting new opportunities across biomarker discovery, pharmaceutical research, drug development, and longitudinal molecular measurement.
"We believe access is the foundation," said Dr. Martini in the Life Sciences Review feature. "Our goal has never been just to collect another biological sample. It is to create a platform that expands practical access to meaningful biological information."
The article also explores the potential for longitudinal molecular data to advance understanding of biological change over time, including applications in therapeutic response, oncology, neuroscience, and other areas of biological research.
KIFFIK continues to advance its K-EXP™ platform and development programs, with a focus on expanding access to biological information and enabling new insights into human biology.
Beyond his role at KIFFIK, Dr. Martini is CEO of PHTA Ltd, the University of Birmingham's flagship life sciences research and innovation facility. Learn more at PHTA.co.uk.
Read the full KIFFIK Biomedical feature: Life Sciences Review - October 2026, page 33
About KIFFIK Biomedical
KIFFIK Biomedical is a biotechnology company developing technology designed to provide non-invasive access to interstitial fluid (ISF), an information-rich biological fluid that has historically been difficult to access. Access to ISF expands biological visibility and enables new insights into human biology.
For more information, visit www.KIFFIK.com.
This device is not FDA approved. For investigational use only.
The recognition was determined through Life Sciences Review's editorial process. KIFFIK participated in an associated paid promotional program.
Media Contact
Darbi James
EVP, Corporate Development
KIFFIK Biomedical, Inc.
[email protected]
SOURCE: Kiffik
View the original press release on ACCESS Newswire
L.Adams--AT
